Purification of IgD. TEPC-1017 ascites was passed over a column of rabbit anti-mouse lgD-coupled Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ). After extensive washing with phosphate-buffered saline (PBS), the IgD was eluted with 4.0 M MgCl~. The eluate was dialyzed and reconstituted to the same volume as the original ascites fluid.
Spleen Cell Fractionation. Adherent cells were removed by incubation of spleen cells in tissue culture grade petri dishes (1400-1; Nunclon, Roskilde, Denmark) at 37°C for 1 h. T cells were eliminated by complement (C)-mediated cytolysis using a monoclonal antibody to Thy-l.2 (6.80) provided by Dr. U. Hammerling (Sloan-Kettering Institute, New York). L3T4 ÷ cells were eliminated by treatment of spleen cells with C and the monoclonal antibody GK1.5 (5), provided by Dr. F. Fitch, (University of Chicago, IL). Splenic T cells were purified by negative selection with the use of goat anti-mouse Igcoated petri dishes at 4°C as described (6) . Lyt-l+2 -T cells were prepared from isolated T cells by C-mediated cytolysis using the monoclonal antibody 19/178 (7) provided by Dr. U. Hammerling (Sloan-Kettering Institute).
In some experiments, isolated T cells were exposed to IgD-or IgA-containing ascites fluid using either TEPC-1017-or MOPC-167-coated petri dishes, respectively. Briefly, bacteriological grade, 100-ram petri dishes (Fisher Scientific Co., Pittsburgh, PA) were coated for 1 h at room temperature with 10 ml Tris buffer, pH 9.5, containing 6 mg of ascites protein from either the TEPC-1017 or MOPC-167 plasmacytoma. After three washes with PBS containing 2% fetal calf serum, 3 x 107 T cells suspended in 4 ml of PBS were added and the plates were further incubated at 37°C for 1 h. After this incubation procedure, cells were vigorously triturated to remove them from the dish and the harvested cells were washed three times with PBS.
Cell Transfer. Unless otherwise indicated, 107 spleen ceils, suspended in saline, were injected intravenously into recipients that had received 100 rad whole-body 3, irradiation 1 d earlier from a 1~7Cs source (Isomedix, Inc., Parsippany, NJ).
Plaque-forming Cell (PFC) Assay. Anti-TNP PFC were assayed by the slide modification of the technique ofJerne et al. (8) . TNP sheep erythrocytes (SE) were prepared using the method described by Rittenberg and Pratt (9) . IgG-producing cells were developed with rabbit anti-mouse Ig in the complement and goat anti-# in the agar (10) . Background anti-SE PFC were routinely determined. Mean anti-SE responses in all control and experimental groups were always <1,000 PFC/spleen.
Rosette-forming Cell (RFC) Assay. IgD-coated indicator cells were prepared by coupling affinity-purified IgD to SE using the CrCI3 coupling method of Poston (11) . Coupling of IgD to SE was confirmed both by positive hemagglutination and indirect immunofluorescence assays using a rabbit anti-mouse IgD antiserum. Enumeration of IgD-RFC was performed as previously described (2) . Lymphocytes surrounded by more than three indicator cells were scored as rosettes and the results expressed as percent RFC. In each experiment, the percentage of cells forming rosettes with SE was determined and was always <2%.
Results

Transfer of the Augmentation of the Response to TNP-KLH by T Cells Exposed to
IgD In Vivo. The results in experiments I, 2, and 3 in Table I show that transfer of spleen cells from IgD-pretreated donors, simultaneously injected, intravenously, with TNP-KLH, led to enhanced responses in 3,-irradiated (100 rad) recipients. Similar results were obtained using unirradiated recipients (Table I , Exp. 4). Normal spleen cells did not significantly raise the response above that of mice receiving antigen alone (Exp. 1). Spleen cells, depleted of Ig-bearing cells by panning on anti-Ig-coated petri dishes, transferred the IgD-induced augmentation of the immune response, whereas anti-Thy-l.2 and C-treated spleen cells from IgD-pretreated donors did not transfer augmentation (Exp. 2, Table I ). Similarly, donor spleen cells from IgD-pretreated mice failed to transfer (Fig. 1) . The incidence of IgD-RFC in these cell populations from IgD-pretreated mice was also determined (Fig. 2) . The background IgD-RFC was <5% for all cell populations studied. Splenic B cells from IgD pretreated donors showed an IgD-RFC frequency barely above this background. We have recently reported (2) that L3T4-T cells from IgD-pretreated mice also show only background levels of IgD-RFC. In contrast, both unfractionated and Lyt-l+2 -T cells demonstrated a significantly increased percentage of IgD-RFC, ranging from 20 to 30% (Fig.   2) .
IgD In Vitro. In previous studies (2) it was shown that overnight incubation at Fig. 3 show that incubation for 1 h in IgD-coated petri dishes, induced the appearance of IgD receptors on a large percentage of T cells, whereas cells incubated in IgA-coated or uncoated petri dishes did not. Whole spleen or splenic T cells were examined for their ability to augment immune responses in 100-rad-3,-irradiated recipients after 1 h preincubation in vitro in petri dishes coated with IgD-or with IgA-containing ascites fluid or left uncoated (Table II) . Cells from normal donors incubated in IgD-coated dishes enhanced the immune response of recipients as compared with the responses of mice that received either antigen alone or antigen and cells incubated in uncoated dishes. It should be noted that the TNP-KLH preparation used in Exp. 2, Table  II induced much higher responses than the preparation used in the other experiments. However, the enhancement obtained with IgD-exposed T cells was still 56% for 19S (P = 0.02) and 79% for 7S (P < 0.01) as compared with 37% for 19S (P = 0.02) and 0% for 7S with cells incubated on uncoated dishes. Cells incubated in IgA-coated petri dishes, on the other hand, appeared to cause a suppression of the immune response in recipients. To rule out the possibility that the enhancement by cells incubated with IgD was actually due to the injection of IgD which leached off the dish during incubation, thymocytes were similarly exposed to IgD-coated dishes and transferred. The responses in recipients of 
FIGURE 3. Incidence of lgD-RFC in BALB/c T cells after incubation in dishes coated with
IgD-containing ascites (TEPC-1017), lgA-containing ascites (MOPC-167), or in uncoated petri dishes. The incubation period was 1 h at 37°C followed by the RFC assay as described in Materials and Methods.
these cells were no higher than in recipients of antigen alone (data not shown). It was previously shown (2) that thymocytes cannot be induced to exhibit IgD-RFC by incubation with IgD. The response in recipients of IgD-pretreated donor cells incubated in uncoated dishes (Exp. 1, Table II) was significantly higher than that in recipients of normal Table II , when splenic T cells isolated from IgD-pretreated donors were reexposed to IgD in vitro, their ability to enhance the response in recipients was further enhanced as compared with T cells incubated either on uncoated or in IgA-coated petri dishes (P = 0.03 for 19S and P = 0.01 for 7S PFC).
Lack of Strain Specificity of the Effects of lgD. In previous experiments (2) it was
shown that IgD-RFC can be induced by exposure to IgD of a allotype in spleen ceils from b allotype congenic C.B20 mice. In addition, IgD-injected C.B20 mice showed significantly enhanced anti-TNP PFC responses (2) . It was of interest to determine whether exposure of T cells from a mouse strain of different genetic background to TEPC-1017 protein had similar effects. Overnight incubation of CBA/J spleen cells at 37 °C in IgD-containing medium caused the appearance of 29.4 + 1.9% IgD-RFC (n = 9). The results in Fig. 4 show, in addition, that T cells from normal CBA/J spleen cells incubated in IgD-coated petri dishes significantly enhanced both the 19S and 7S PFC responses to TNP-KLH of 100-rad 7-irradiated syngeneic mice.
Discussion
The present results establish for the first time the existence of immunoaugmenting T cells that are induced, either in vivo or in vitro, by exposure to IgD. Pretreatment of donors with IgD induced the appearance of a population of Lyt-1+2 -T cells with both receptors for IgD (T6) and the ability to transfer augmentation of the immune responses to lightly irradiated or unirradiated recipients. B cells from such IgD-pretreated donors or spleen cells from which only the L3T4 + T cells had been removed did not transfer immunoaugmentation and did not show increased rosette formation with IgD-coated SE. These results agree with our previous observation (2) that IgD-RFC induced by treatment with IgD in vivo are predominantly L3T4 ÷, Lyt-1 +, Lyt-2-. In addition, the kinetics of the appearance of these IgD-RFC after injection of IgD in vivo correlates with the enhancement of immune responses in IgD-injected mice (2) .
The augmenting effect of spleen cells incubated in IgD-coated petri dishes was probably not due to cotransfer of IgD, since the petri dishes had been extensively rinsed to remove any weakly bound IgD, and thymus cells incubated on IgDcoated petri dishes did not cause immunoaugmentation. Previous experiments (2) have shown that IgD-RFC can be induced in spleen and lymph node cells, but not in thymus cells after in vivo or in vitro exposure to IgD. The observation that IgD also induces immune-augmenting properties and IgD-RFC in T cells from CBA mice, indicates that these effects are not strain specific. This is consistent with our previous finding (2) of augmentation of the immune response by IgD of a allotype in b ailotype C.B20 mice, indicating a lack of allotype specificity. Previous studies have shown that the injection of antigen (2) or allo anti-IgD (Coico, unpublished results) induces the appearance of significantly increased numbers of IgD-RFC (11 and 41%, respectively) by day 5 after injection in BALB/c mice. It is possible that the augmentation of immune responses previously shown to occur after injection of heterologous anti-IgD (12, 13) is, in part, the result of the induction of T6 cells, although an enhanced response to the foreign Ig bound to B cells, as shown by Finkeiman et al. (14) , clearly plays an important part in this enhancement. It is probable that the augmenting effect of allotype-specific murine anti-IgD on the immune response to TNP-KLH of the alternate allotype in heterozygous mice (15) is due to induction of Tb cells.
The immunoaugmenting effect of two injections of IgD 1 wk apart was previously shown to be greater than that of a single IgD injection (2) . This is consistent with the present results showing that reexposure of T cells from IgDpretreated mice to IgD in vitro further increases their immunoaugmenting capability. Since the frequency of IgD-RFC is already at maximal levels 7 d after a single injection of IgD, it seems possible that, as we suggested previously (2), the reexposure to IgD increases the avidity of the T6 cells for IgD either by increasing the number of receptors or their affinity.
IgD injection or transfer ofT6 cells did not cause an increase in the background PFC to SE. Thus, the immunoaugmentation appears to be antigen dependent. We propose that the augmenting effect ofT6 cells is mediated by their interaction with surface IgD on B cells that are in the process of reacting with antigen, and not by recognition of IgD on the surface of resting B cells. These findings provide a biological rationale for the presence of IgD on the B cell surface and its relatively low concentration in serum. It might be presumed that, after its reaction with antigen, B cell surface IgD receives a signal from Ta cells. The T6 cells may either be induced by increased serum IgD levels, or possibly by IgDantigen immune complexes in serum or on the B cell surface itself. It is interesting to note that both IgD-secreting myelomas (TEPC-I 017 and TEPC-1033) secrete IgD molecules which, on polyacrylamide gel electrophoresis, appear to be oligomers rather than monomers (4). Thus, we are proposing the existence of a regulatory circuit based upon interaction between T6 cells, antigen, B cell surface IgD, and serum IgD. In addition, the possible role of passively acquired IgDantigen complexes on the T cell surface in the induction of idiotype-antiidiotype circuits needs to be evaluated.
Summary
We show that the IgD-induced augmentation of the immune response to trinitrophenylated keyhole limpet hemocyanin can be transferred to syngeneic mice with spleen cells from IgD-injected donors. The augmenting activity is present in the Lyt-l+2 -, L3T4 ÷ T cell population and is absent from B cells. The ability of transferred T cells to augment the immune response correlates with the presence of a high frequency of Lyt-1 +2-T cells that form rosettes with IgDcoated sheep erythrocytes (T6 cells). Such rosette-forming cells can also be induced by incubation of spleen ceils from normal donors in IgD-coated petri dishes. Injection of normal spleen cells exposed to IgD-coated petri dishes together with antigen also augments the immune response of recipients. The existence of a regulatory circuit based upon interactions between T6 cells, antigen, B cell surface IgD, and serum IgD, is proposed.
